2008
DOI: 10.1016/s1098-3015(10)66662-4
|View full text |Cite
|
Sign up to set email alerts
|

Pdb15 Comparative Cost-Utility Analysis of Long-Acting Insulin Analogue (Insulin Detemir) and NPH Insulin for the Treatment of Type 1 and Type 2 Diabetes and the Budget Impact Analysis of Insulin Analogue Reimbursement in Poland

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles